1337 related articles for article (PubMed ID: 18809796)
1. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
[TBL] [Abstract][Full Text] [Related]
4. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
Maron MS; Olivotto I; Zenovich AG; Link MS; Pandian NG; Kuvin JT; Nistri S; Cecchi F; Udelson JE; Maron BJ
Circulation; 2006 Nov; 114(21):2232-9. PubMed ID: 17088454
[TBL] [Abstract][Full Text] [Related]
5. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
[TBL] [Abstract][Full Text] [Related]
6. Successful catheter ablation of hemodynamically unstable monomorphic ventricular tachycardia in a patient with hypertrophic cardiomyopathy and apical aneurysm.
Lim KK; Maron BJ; Knight BP
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):445-7. PubMed ID: 19054248
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the prevalence, clinical features, and long-term outcomes of midventricular hypertrophy vs apical phenotype in patients with hypertrophic cardiomyopathy.
Cai C; Duan FJ; Yang YJ; Guo XY; Liu YL; Liu YQ; Yan LR; Xu ZM; Zhao SH; Hua W; Li YS; Fan CM
Can J Cardiol; 2014 Apr; 30(4):441-7. PubMed ID: 24468417
[TBL] [Abstract][Full Text] [Related]
8. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
[TBL] [Abstract][Full Text] [Related]
11. Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy.
Fattori R; Biagini E; Lorenzini M; Buttazzi K; Lovato L; Rapezzi C
Am J Cardiol; 2010 Jun; 105(11):1592-6. PubMed ID: 20494668
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy.
Jayatilleke I; Doolan A; Ingles J; McGuire M; Booth V; Richmond DR; Semsarian C
Am J Cardiol; 2004 May; 93(9):1192-4. PubMed ID: 15110224
[TBL] [Abstract][Full Text] [Related]
13. Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance.
Maron MS; Lesser JR; Maron BJ
Am J Cardiol; 2010 Jun; 105(12):1842-3. PubMed ID: 20538141
[TBL] [Abstract][Full Text] [Related]
14. [The role of magnetic resonance in studying hypertrophic cardiomyopathy: the echocardiographic correlations and clinical implications].
Rapezzi C; Fattori R; Castriota F; Passarelli P; Magnani G; Galiè N; Ferlito M; Bertaccini P; Branzi A; Gavelli G
Cardiologia; 1994 Jan; 39(1):7-15. PubMed ID: 8020058
[TBL] [Abstract][Full Text] [Related]
15. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
[TBL] [Abstract][Full Text] [Related]
17. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.
Maron MS; Appelbaum E; Harrigan CJ; Buros J; Gibson CM; Hanna C; Lesser JR; Udelson JE; Manning WJ; Maron BJ
Circ Heart Fail; 2008 Sep; 1(3):184-91. PubMed ID: 19808288
[TBL] [Abstract][Full Text] [Related]
18. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P
J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of left ventricular apical aneurysms in hypertrophic cardiomyopathy patients: the role of diagnostic electrocardiography.
Ichida M; Nishimura Y; Kario K
J Cardiol; 2014 Oct; 64(4):265-72. PubMed ID: 24674752
[TBL] [Abstract][Full Text] [Related]
20. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.
Maron MS; Olivotto I; Harrigan C; Appelbaum E; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Maron BJ
Circulation; 2011 Jul; 124(1):40-7. PubMed ID: 21670234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
